Boston Scientific Files 8-K on Financials
Ticker: BSX · Form: 8-K · Filed: Jul 24, 2024 · CIK: 885725
| Field | Detail |
|---|---|
| Company | Boston Scientific CORP (BSX) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k, reporting
Related Tickers: BSX
TL;DR
BSX dropped an 8-K on July 24th detailing their financial results. Check it out.
AI Summary
Boston Scientific Corporation (BSX) filed an 8-K on July 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. The report details the company's fiscal year end as December 31st.
Why It Matters
This filing provides investors with crucial updates on Boston Scientific's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any unusual or immediate risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's annual financial reporting period.)
Key Players & Entities
- Boston Scientific Corporation (company) — Registrant
- BSX (company) — Ticker Symbol
- July 24, 2024 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 300 Boston Scientific Way, Marlborough, Massachusetts (address) — Business Address
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these results are not provided in the provided text.
When was this 8-K filed?
The 8-K was filed on July 24, 2024.
What is Boston Scientific Corporation's state of incorporation?
Boston Scientific Corporation is incorporated in Delaware.
What is the business address of Boston Scientific Corporation?
The business address is 300 Boston Scientific Way, Marlborough, Massachusetts.
What is the fiscal year end for Boston Scientific Corporation?
The fiscal year end for Boston Scientific Corporation is December 31st.
Filing Stats: 515 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-07-24 06:35:23
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share BSX New York Stock
Filing Documents
- bsx-20240724.htm (8-K) — 27KB
- q22024earningsrelease.htm (EX-99.1) — 370KB
- imagea.jpg (GRAPHIC) — 37KB
- 0000885725-24-000060.txt ( ) — 635KB
- bsx-20240724.xsd (EX-101.SCH) — 3KB
- bsx-20240724_def.xml (EX-101.DEF) — 15KB
- bsx-20240724_lab.xml (EX-101.LAB) — 27KB
- bsx-20240724_pre.xml (EX-101.PRE) — 16KB
- bsx-20240724_htm.xml (XML) — 4KB
02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On July 24, 2024, Boston Scientific Corporation issued a press release announcing financial results for the second quarter ended June 30, 2024. A copy of the release is furnished with this report as Exhibit 99.1. The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Boston Scientific Corporation dated July 24, 2024 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 24, 2024 BOSTON SCIENTIFIC CORPORATION By: /s/ Susan Thompson Susan Thompson Vice President, Chief Corporate Counsel and Assistant Secretary